These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23590878)

  • 1. Prediction of antiplatelet effects of aspirin in vivo based on in vitro results.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    Clin Appl Thromb Hemost; 2013; 19(6):600-7. PubMed ID: 23590878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences.
    Anzellotti P; Capone ML; Jeyam A; Tacconelli S; Bruno A; Tontodonati P; Di Francesco L; Grossi L; Renda G; Merciaro G; Di Gregorio P; Price TS; Garcia Rodriguez LA; Patrignani P
    Arthritis Rheum; 2011 Mar; 63(3):850-9. PubMed ID: 21360514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of platelet aggregation responses in microminipigs: Comparison with miniature pigs and the influence of dual antiplatelet administration of aspirin plus prasugrel.
    Ohno K; Tomizawa A; Jakubowski JA; Mizuno M; Sugidachi A
    Thromb Res; 2015 May; 135(5):933-8. PubMed ID: 25776467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
    Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
    Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why an aspirin a day no longer keeps the doctor away ….
    Lordkipanidzé M
    Thromb Haemost; 2011 Feb; 105(2):209-10. PubMed ID: 21136021
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally given gastroprotective capsaicin does not modify aspirin-induced platelet aggregation in healthy male volunteers (human phase I examination).
    Sandor B; Papp J; Mozsik G; Szolcsanyi J; Keszthelyi Z; Juricskay I; Toth K; Habon T
    Acta Physiol Hung; 2014 Dec; 101(4):429-37. PubMed ID: 25532954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antiplatelet effects of clopidogrel plus acetylsalicylic acid compared with acetylsalicylic acid alone or combined with extended-release dipyridamole in healthy volunteers.
    Caplain H
    Cerebrovasc Dis; 2005; 19(4):214-9. PubMed ID: 15703464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.
    Lev EI; Ramabadran RS; Guthikonda S; Patel R; Kleiman A; Granada JF; DeLao T; Kleiman NS
    Am J Cardiol; 2007 Jan; 99(1):124-8. PubMed ID: 17196475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
    Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
    J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
    Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
    Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin.
    Yokoyama H; Ito N; Soeda S; Ozaki M; Suzuki Y; Watanabe M; Kashiwakura E; Kawada T; Ikeda N; Tokuoka K; Kitagawa Y; Yamada Y
    J Clin Pharm Ther; 2013 Feb; 38(1):12-5. PubMed ID: 22882748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of anti-platelet effect after oral aspirin administration in patients with sympathetic excitement.
    Nishiyama A; Niikawa O; Mohri H; Tsushima M
    Circ J; 2003 Aug; 67(8):697-700. PubMed ID: 12890913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.
    Hosokawa K; Ohnishi T; Sameshima H; Miura N; Ito T; Koide T; Maruyama I
    Thromb Haemost; 2013 Jan; 109(1):102-11. PubMed ID: 23179055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet function tests.
    Shenkman B; Matetzky S; Fefer P; Hod H; Einav Y; Lubetsky A; Varon D; Savion N
    Thromb Res; 2008; 122(3):336-45. PubMed ID: 18155752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of transdermic acetylsalicylic acid on hemostasis in healthy volunteers.
    Martínez AB; Funosas E; Maestri L; Lucena PH
    Acta Odontol Latinoam; 2007; 20(1):3-8. PubMed ID: 18046964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.